Table 3

Numbers of adverse events in the risk and control periods, included in the self-controlled case series analysis

Adverse eventsPeriodVaccines
DTaP/IPV or dTaP/IPVDTaP/IPV/HibHib/MenCHPVMenBMenCMMRPCVRVTd/IPV
n%n%n%n%n%n%n%n%n%n%
FeverRisk46201.030890.712 7332.92550.11 7280.43 6840.813 7513.13 9820.92 2270.53790.1
Control441 60399.0443 13499.3433 49097.1445 96899.9444 49599.6442 53999.2432 50896.9442 24199.1443 99699.5445 84499.9
GastrointestinalRisk22060.510 5492.499692.35200.13 3110.811 1912.610 6622.513 0623.05 6841.36340.1
Control430 3039.5429 19897.6422 54097.7431 98999.9429 19899.2421 31897.4421 84797.5419 44797.0426 82598.7431 87599.9
General symptomsRisk5570.28290.31 0160.41 1570.52800.18460.31 2490.51 0720.44390.21 1150.5
Control244 68399.8244 41199.7244 22499.6244 08399.5244 96099.9244 39499.7243 99199.5244 16899.6244 80199.8244 12599.5
Local symptomsRisk5420.8176.63112.010.493.5228.54216.23112.083.151.9
Control20579.224293.422888.025899.625096.523791.521784.822888.025196.925498.1
MusculoskeletalRisk4730.3540.02550.25270.4350.0810.13300.2760.1360.05260.4
Control136 36299.7136 781100.0136 58099.8136 30899.6136 800100.0136 75499.9136 50599.8136 75999.9136 799100.0136 30999.6
NeurologicalRisk1870.61680.58602.7430.1630.22050.61 0123.12120.7850.3360.1
Control32 17699.432 19599.531 50397.332 32099.932 30099.832 15899.431 35196.932 15199.332 27899.732 32799.9
RashRisk35670.76 3531.211 7092.36300.124900.58 0101.613 6222.780601.63 9340.87120.1
Control507 52399.3504 73798.8499 38197.7510 46099.9508 60099.5503 08098.4497 46897.3503 03098.4507 15699.2510 37899.9
Respiratory / MiscRisk11 5270.725 8331.528 2141.72 5339.28 7070.529 1911.731 6421.932 9172.014 2670.82 5060.1
Control1 668 33799.31 654 03198.51 651 65098.31 677 33199.81 671 15799.51 650 76398.31 648 22298.11 646 94798.01 665 59799.21 677 35899.9
Sensitivity / AnaphylaxisRisk3531.01540.54771.41180.4720.22010.65051.51940.61070.31190.4
Control33 31199.033 51099.533 18798.633 54699.633 59299.833 46399.433 15998.533 47099.433 55799.733 54599.6